Michael Goldfarb, MD
Dermatology · Dearborn, MINPI 1467422923
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by UCB, Inc. at 40.6% of the total. That places this record below the midpoint for dermatology clinicians in MI, where the typical reported total is $2,933.
Across 44 payments — averaging $70.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Astrazeneca UK Limited$851
- Sanofi$245
- Dermavant Sciences, Inc.$230
- Johnson & Johnson$146
- Boehringer Ingelheim$73
- plus $289 from 10 others
Across 118 payments — averaging $4483.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$206K
- Takeda Pharmaceuticals U.S.A., Inc.$199K
- Janssen Research & Development, LLC$113K
- E.r. Squibb & Sons, L.L.C.$10K
- Regeneron$981
What the payments were for
- Consulting fees$1,12036%
- Speaking & faculty fees$2458%
- Travel & lodging$59619%
- Food & beverage$96631%
- Education$1625%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 2 | $1,254 |
| Astrazeneca UK Limited | 7 | $851 |
| Sanofi | 1 | $245 |
| Dermavant Sciences, Inc. | 15 | $230 |
| Johnson & Johnson | 2 | $146 |
| Boehringer Ingelheim | 1 | $73 |
| E.r. Squibb & Sons, L.L.C. | 3 | $63 |
| AbbVie | 3 | $49 |
| Botanix SB Inc | 2 | $39 |
| Organon | 2 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Pfizer | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| LEO Pharma Inc. | 1 | $15 |
| Janssen Research & Development, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,089 in reported general payments places this provider in the 50th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 20 | $104,459 |
| Calcipotriene | 28 | $6,917 |
| Clobetasol Propionate | 184 | $6,019 |
| Metronidazole | 86 | $3,493 |
| Ketoconazole | 206 | $3,230 |
| Mometasone Furoate | 204 | $3,083 |
| Clindamycin Phosphate | 68 | $1,630 |
| Desonide | 54 | $1,477 |
| Ammonium Lactate | 73 | $1,391 |
| Mupirocin | 185 | $1,390 |
| Fluorouracil | 21 | $1,140 |
| Azelaic Acid | 15 | $1,137 |
| Halobetasol Propionate | 22 | $1,040 |
| ValacyclovirValacyclovir Hcl | 57 | $1,035 |
| Triamcinolone Acetonide | 77 | $831 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Dearborn
- Steven DaveluyDearborn$350K
- Linda Stein GoldWest Bloomfield$3.3M
- Kristi HawleyCaledonia$2.2M
- David AltmanWarren$1.9M
- Michael SiegelWaterford$708K
- Johann GudjonssonAnn Arbor$535K
- Michael DormanWest Bloomfield$433K
- Benjamin WorkmanMidland$284K
- Diana WestgateKalamazoo$252K
- Christofer BuattiAuburn Hills$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.